Carroll Investors’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.95M | Buy |
385,602
+44,271
| +13% | +$224K | 1.03% | 16 |
|
|
2025
Q1 | $1.81M | Buy |
341,331
+94,346
| +38% | +$500K | 1.2% | 14 |
|
|
2024
Q4 | $1.67M | Buy |
246,985
+84,245
| +52% | +$569K | 0.94% | 15 |
|
|
2024
Q3 | $1.08M | Buy |
162,740
+81,974
| +101% | +$542K | 0.71% | 17 |
|
|
2024
Q2 | $606K | Buy |
80,766
+66,967
| +485% | +$502K | 0.42% | 17 |
|
|
2024
Q1 | $138K | Buy |
+13,799
| New | +$138K | 0.1% | 23 |
|